Skip to main content
SpringerLink
Log in

Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: A biochemical and histomorphometric study

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

The mechanisms underlying glucocorticoid-induced osteoporosis in humans are a defect in bone formation associated with increased bone resorption. The latter may be due to elevated parathyroid hormone (PTH) levels induced by the impairment of intestinal calcium absorption caused by corticosteroids. In this study we analysed the effects of corticosteroids in old ewes, a potential model for the study of human bone turnover. Two groups of seven 9-year-old female sheep were selected. The first group was injected intramuscularly with a daily dose of 30 mg methylprednisone (MP) during the first 2 months and 15 mg during the last month. After 2 and 3 months of treatment, blood samples were taken. At the end of the experiment the animals were slaughtered and the iliac crest kept for bone histomorphometry. Serum osteocalcin (sOC) rapidly and markedly decreased in the MP-treated group compared with controls (−77%;p<0.01). In contrast, at the end of the experiment serum calcium and PTH levels were similar in both groups. Histomorphometric analysis showed a significant reduction in the wall width of trabecular packets. Dynamic parameters reflecting bone formation at the tissue and cell levels were significantly lower in the MP-treated group than in controls, with a highly significant decrease in the mineralization rate (MAR: −63%,p<0.05) and double-labeled perimeter (dLPm/B.Pm: −92%p<0.05). The bone formation rate (BFR/B.Pm) also decreased by 84% and the adjusted apposition rate (Aj.AR) by 80%. The increase in the total formation period was mainly due to an increase in the inactive period. Significant correlations were found between sOC and MAR, dLPm/B.Pm and BFR/B.Pm (withr′ respectively 0.67, 0.76 and 0.51). In conclusion, the effects of corticosteroid on ewe bone remodeling are essentially characterized by a major bone formation defect without evidence of secondary hyperparathyroidism, although this cannot be totally excluded by our results. Ewes treated with glucocorticoids could represent a good model for evaluating the effects of drugs candidates for all bone conditions characterized by reduced bone formation resulting from osteoblastic depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bressot C, Meunier PJ, Chapuy MC, et al. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1979;1:303–11.

    Google Scholar 

  2. Hahn TJ, Halstead LR, Teitelbaum SL, et al. Altered mineral metabolism in glucocorticoid-induced osteopenia: effect of 25-hydroxyvitamin D administration. J Clin Invest 1979;64:655–65.

    Google Scholar 

  3. Lukert BP, Adams JS. Calcium and phosphorus homeostasis in man: effect of corticosteroids. Arch Intern Med 1976;136:1249–53.

    Google Scholar 

  4. Dempster DW. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 1989;4:137–41.

    Google Scholar 

  5. Lund B, Storm TL, Lund B, et al. Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment. Clin Rheumatol 1985;4:143–9.

    Google Scholar 

  6. Dempster DW, Arlot MA, Meunier PJ. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 1983;35:410–7.

    Google Scholar 

  7. Meunier PJ, Dempster DW, Edouard C, et al. Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome. Adv Exp Med Biol 1984;171:191–200.

    Google Scholar 

  8. Chen TL, Aronow L, Feldman D. Glucocorticoid receptors and inhibition of bone cell growth in primary culture. Endocrinology 1977;100:619–28.

    Google Scholar 

  9. McCulloch CAG, Tenenbaum HC. Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture. Anat Rec 1986;215:397–402.

    Google Scholar 

  10. Guenther HL, Felix R, Fleisch H. Comparative study of deflazacort a new synthetic corticosteroid, and dexamethasone on the synthesis of collagen in different rat bone cell populations and rabbit articular chondrocytes. Calcif Tissue Int 1984;36:145–52.

    Google Scholar 

  11. Dietrich JW, Canalis EM, Maina DM, et al. Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 1979;104:715–21.

    Google Scholar 

  12. Chavassieux P, Pastoureau P, Boivin G, et al. Dose effects on ewe bone remodeling of short-term sodium fluoride administration: a histomorphometric and biochemical study. Bone 1991;12:421–8.

    Google Scholar 

  13. Dielh M, Ellingboe J. Indicator for titration of calcium in presence of magnesium using disodium dihydrogen ethylene diamine tetraacetate. Clin Chemistry 1950;28:882–4.

    Google Scholar 

  14. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925;66:375–80.

    Google Scholar 

  15. Pastoureau P, Merle B, Delmas PD. Specific radioimmunoassay for ovine bone-Gla protein. Acta Endocrinol (Copenh) 1988;113:152–60.

    Google Scholar 

  16. Conaway JJ, Anast CS. Double antibody radioimmunoassay for parathyroid hormone. J Lab Clin Med 1974;83:129–40.

    Google Scholar 

  17. Meunier PJ. Histomorphometry of the skeleton. In: Peck WA, editor. Bone and mineral research, annual 1. Amsterdam: Excerpta Medica, 1983:191–222.

    Google Scholar 

  18. Schenk RK, Olah AJ, Herrmann W. Preparation of calcified tissues for light microscopy. In: Dickson GR, editor. Methods of calcified tissue preparation. Amsterdam: Elsevier, 1984:1–56.

    Google Scholar 

  19. Chavassieux PM, Arlot ME, Meunier PJ. Intermethod variation in bone histomorphometry: comparison between manual and computerized methods applied to iliac bone biopsies. Bone 1985;6:221–9.

    Google Scholar 

  20. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry standardization of nomenclature, symbols and units. J Bone Miner Res 1987;2:595–610.

    Google Scholar 

  21. Kragstrup J, Gundersen HJG, Melsen F, et al. Estimation of the three-dimensional wall thickness of completed remodeling sites in iliac trabecular bone. Metab Bone Dis Rel Res 1982;4:113–9.

    Google Scholar 

  22. Vedi S, Compston JE, Webb A, et al. Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Rel Res 1983;5:69–74.

    Google Scholar 

  23. Melsen F, Mosekilde L. Trabecular bone mineralization lag time determined by tetracycline double-labeling in normal and certain pathological conditions. Acta Pathol Microbiol Scand [A] 1980;88:83–8.

    Google Scholar 

  24. Gallagher JC, Aaron J, Horsman A, et al. Corticosteroid osteoporosis. Clin Endocrinol Metab 1973;2:355–68.

    Google Scholar 

  25. Stellon AJ, Webb A, Compston JE. Bone histomorphometry and structure in corticosteroid-treated active hepatitis. Gut 1988;29:378–84.

    Google Scholar 

  26. Reid I, Chapman G, Fraser T, et al. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab 1986;62:379–83.

    Google Scholar 

  27. Lukert BP, Higgins JC, Stoskopf MM. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 1986;62:1056–8.

    Google Scholar 

  28. Gennari C, Imbimbo B, Montagnani M, et al. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 1984;36:245–52.

    Google Scholar 

  29. Baylink DJ. Glucorticoid-induced osteoporosis. N Engl J Med 1983;309:306–8.

    Google Scholar 

  30. Avioli LV. Effects of chronic corticosteroid therapy on mineral metabolism and calcium absorption. Adv Exp Med Biol 1984;171:81–9.

    Google Scholar 

  31. Need AG, Hartley TF, Philcox JC, et al. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women. Aust NZ J Med 1986;16:341–6.

    Google Scholar 

  32. Fucik RF, Kukreja SC, Hargis GK, et al. Effects of glucocorticoids on parathyroid glands in man. J Clin Endocrinol Metab 1975;40:152–5.

    Google Scholar 

  33. Williams GA, Peterson WC, Bowser EN, et al. Interrelationship of parathyroid and adrenocortical function in calcium homeostasis in the rat. Endocrinology 1974;95:707–12.

    Google Scholar 

  34. Seeman E, Kumar R, Hunder GG, et al. Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Invest 1980;66:664–9.

    Google Scholar 

  35. Stern PH. Inhibition by steroids of parathyroid hormone-induced45Ca release from embryonic rat bone in vitro. J Pharmacol Exp Ther 1969;168:211–7.

    Google Scholar 

  36. Raisz LG, Trummel CL, Wener JA, et al. Effect of glucocorticoids on bone resorption in tissue culture. Endocrinology 1972;90:961–5.

    Google Scholar 

  37. Lowe C, Gray DH, Reid R. Serum blocks the osteolytic effect of cortisol in neonatal mouse calvaria. Calcif Tissue Int 1992,50:189–92.

    Google Scholar 

  38. Tobias J, Chambers TJ. Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones. Endocrinology 1989;125:1290–5.

    Google Scholar 

  39. Sugimoto T, Brown AJ, Ritter C, Morrissey J, Slatopolsky E, Martin KJ. Combined effects of dexamethasone and 1,25-dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells. Endocrinology 1989;125:638–41.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. INSERM Unité 234, Faculté Alexis Carrel, rue G. Paradin, 69372, Lyon Cedex 08, France

    P. Chavassieux MD, P. Pastoureau, M. C. Chapuy, P. D. Delmas & P. J. Meunier

Authors
  1. P. Chavassieux MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Pastoureau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. C. Chapuy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. D. Delmas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. J. Meunier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chavassieux, P., Pastoureau, P., Chapuy, M.C. et al. Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: A biochemical and histomorphometric study. Osteoporosis Int 3, 97–102 (1993). https://doi.org/10.1007/BF01623380

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01623380

Keywords

Search

Navigation